荃銀高科(300087.SZ):部分董監高、核心骨幹、安徽張海銀種業基金會擬設合夥企業 跟投公司投資的項目
格隆匯 9 月 14日丨荃銀高科(300087.SZ)公佈,為支持公司優質項目的推進和戰略性目標的落實,促進公司項目持續、健康運行,公司部分董事、監事及高級管理人員、核心骨幹即張琴、王玉林、張從合、朱全貴、高勝從、江三橋、張慶一、夏獻鋒、鄭滿生、謝慶軍、王自生、嚴志、趙素珍、呂加林以及安徽張海銀種業基金會等15位合夥人於2020年9月11日簽署《安徽全賢科技合夥企業(有限合夥)合夥協議》,擬共同投資設立註冊資本為500萬元的安徽全賢科技合夥企業(有限合夥)(最終以工商核准名稱為準,“合夥企業”),跟投公司投資的項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.